Company · CIK 0001674930 · SIC 8071 — Services-Medical Laboratories · Nasdaq
Fulgent Genetics, Inc. · FLGT
Insider activity reported against this company. All insider holders · Files at: FLGT. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 SForm 4 → | Sep 3, 7:47 pm EDT | Hanlin GaoChief Scientific Officer | 1,673 | $19.66 | $32,885 | 986,117 | −0.17% | |
| Sep 2, 2026 SForm 4 → | Sep 3, 7:47 pm EDT | Jian XiePresident and COO | 2,127 | $19.66 | $41,809 | 359,924 | −0.59% | |
| Sep 1, 2026 FForm 4 → | Sep 3, 7:48 pm EDT | Paul KimCFO and Treasurer | 2,087 | $19.59 | $40,884 | 356,543 | — | |
| Sep 1, 2026 FForm 4 → | Sep 3, 7:47 pm EDT | Ming HsiehChief Executive Officer, Director, 10% Owner | 4,392 | $19.59 | $86,039 | 885,952 | — | |
| Aug 27, 2026 SForm 4 → | Aug 28, 6:06 pm EDT | Jian XiePresident and COO | 1,193 | $19.91 | $23,747 | 362,051 | −0.33% | |
| Aug 27, 2026 SForm 4 → | Aug 28, 6:05 pm EDT | Hanlin GaoChief Scientific Officer | 939 | $19.91 | $18,691 | 987,790 | −0.09% | |
| Aug 26, 2026 FForm 4 → | Aug 28, 6:06 pm EDT | Ming HsiehChief Executive Officer, Director, 10% Owner | 2,949 | $19.81 | $58,420 | 890,344 | — | |
| Aug 26, 2026 FForm 4 → | Aug 28, 6:06 pm EDT | Paul KimCFO and Treasurer | 1,168 | $19.81 | $23,138 | 358,630 | — | |
| Jul 26, 2026 FForm 4 → | Jul 28, 4:32 pm EDT | Paul KimCFO and Treasurer | 2,747 | $19.67 | $54,033 | 359,798 | — | |
| Jul 26, 2026 FForm 4 → | Jul 28, 4:32 pm EDT | Jian XiePresident and COO | 4,361 | $19.67 | $85,781 | 363,244 | — | |
| Jul 26, 2026 FForm 4 → | Jul 28, 4:32 pm EDT | Hanlin GaoChief Scientific Officer | 1,645 | $19.67 | $32,357 | 988,729 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.